IDT.AX - IDT Australia Limited

ASX - ASX Delayed Price. Currency in AUD

IDT Australia Limited

45 Wadhurst Drive
Boronia, VIC 3155
61 3 9801 8888

IndustryDrug Manufacturers - Major
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. David SparlingInterim Chief Exec. Officer311.92kN/AN/A
Ms. Joanna Johnson BEc, ICAACFO & Joint Company Sec.257.89kN/AN/A
Dr. Graeme L. BlackmanFormer Founder and Director48.58kN/A1946
Jim SosicVP of Operations, Supply & InfrastructureN/AN/AN/A
Ms. Danielle SavaglioVP of People, Change & Internal CommunicationsN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


IDT Australia Limited engages in the development and commercial manufacture of active pharmaceutical ingredients (API) and finished drug products worldwide. The company offers research and development, validation, and testing services for API, including cytotoxics, anti-cancer drugs, antibiotics, beta lactams, and controlled drugs, as well as generic medicines into finished dosage forms. Its services also include laboratory, functional support, project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. The company is headquartered in Boronia, Australia.

Corporate Governance

IDT Australia Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.